Breaking News Instant updates and real-time market news.

BCRX

BioCryst

$3.45

-3.95 (-53.38%)

14:13
05/21/19
05/21
14:13
05/21/19
14:13

BioCryst pullback an overreaction to top-line HAE data, says JMP Securities

JMP Securities analyst Liisa Bayko said BioCryst's BCX7353 showed an "impressive response in a meaningful proportion of patients" and tolerability that was much improved from the Phase 2 trial. She thinks today's greater than 50% pullback in BioCryst shares is an overreaction, stating that her research suggests that about 50% of the HAE market is not on a prophylaxis today. The analyst, who also sees patients being eager to try an oral option, said that BioCryst is conducting more pricing analysis to price below currently available injectables. Bayko keeps an Outperform rating and $18 price target on BioCryst shares, which are down $4.18 to $3.20 per share in afternoon trading.

  • 29

    May

BCRX BioCryst
$3.45

-3.95 (-53.38%)

03/12/19
PIPR
03/12/19
NO CHANGE
PIPR
Biopharma stocks should be up sharply on Sharpless selection, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond said he expects biopharma stocks to be up sharply on news that former National Cancer Institute director Ned Sharpless will be named acting FDA commissioner. The biotech sector "experienced a swoon of sorts" since Scott Gottlieb announced his departure, but with the announcement of Gottlieb's favored choice as successor Raymond believes the FDA will remain "on its current industry-friendly and efficiency driven trajectory," the analyst tells investors.
04/02/19
LEHM
04/02/19
NO CHANGE
Target $8
LEHM
Equal Weight
BioCryst price target raised to $8 from $6 at Barclays
Barclays analyst Gena Wang raised her price target for BioCryst Pharmaceuticals to $8 from $6 following a deep dive ahead of the BCX7353 APeX-2 Phase 3 readout in Q2 for the prevention of hereditary angioedema attacks. The analyst believes APeX-2 is "well powered to allow for statistical significance" with only greater than 25-30% attack reduction. However, she continues to see some risk in the trial outcome and a high bar for future commercial uptake. Wang keeps an Equal Weight rating on BioCryst.
04/22/19
PIPR
04/22/19
NO CHANGE
Target $15
PIPR
Overweight
Piper sees 'significant' potential in HAE for BioCryst after expert call
Piper Jaffray analyst Tyler Van Buren reiterates an Overweight rating on BioCryst Pharmaceuticals with a $15 price target after hosting a call with an expert in hereditary angioedema. A focus of the discussion was on BioCryst's oral capsule and liquid formulations of BCX7353, a plasma kallikrein inhibitor, Van Buren tells investors in a research note. The expert was "quite optimistic" on the Phase III APeX-2 trial reading out later this quarter, and believes that roughly half of all HAE patients would be candidates if a ~50% reduction in attacks is observed with good tolerability, adds the analyst. This suggests "significant" peak sales potential based on a market that is currently $2B-plus and heading towards $3B, says Van Buren. Since CSL and Shire (SHPG) have essentially had a duopoly for years, the expert also believes payors will be very receptive to a less expensive oral option, according to the analyst.
05/21/19
PIPR
05/21/19
NO CHANGE
Target $10
PIPR
Overweight
Piper says BioCryst magnitude of attack reduction in HAE lower than hoped for
After BioCryst announced that the Phase 3 APeX-2 trial of oral BCX7353 for the prevention of hereditary angioedema, or HAE, attacks achieved its primary endpoint, Piper Jaffray analyst Tyler Van Buren noted that the 44% attack reduction observed came in below expectations of greater than 50%. 7353 capsules will likely receive FDA approval and some patients may use it if BioCryst prices it at a meaningful discount, said Van Buren, who pointed out that current treatments cost over $500,000 per year. Following the data report, he reduced his estimate for the penetration of patients on prophylaxis treated to 15% from 30%, leading him to lower his price target on BioCryst shares to $10 from $15. However, Van Buren keeps an Overweight rating on the stock, citing both the significant pullback and the company's capsule+liquid opportunities.

TODAY'S FREE FLY STORIES

RMTI

Rockwell Medical

$4.39

0.2 (4.77%)

17:25
06/17/19
06/17
17:25
06/17/19
17:25
Hot Stocks
Breaking Hot Stocks news story on Rockwell Medical »

Rockwell Medical down 21%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

VRS

Verso

$17.91

-0.24 (-1.32%)

17:21
06/17/19
06/17
17:21
06/17/19
17:21
Hot Stocks
Verso adopts limited duration stockholder rights plan »

Verso announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHVKF

China Vanke Co

$0.00

(0.00%)

17:19
06/17/19
06/17
17:19
06/17/19
17:19
Downgrade
China Vanke Co rating change  »

China Vanke Co downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCKT

Rocket Pharmaceuticals

$16.88

0.68 (4.20%)

17:17
06/17/19
06/17
17:17
06/17/19
17:17
Syndicate
Breaking Syndicate news story on Rocket Pharmaceuticals »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

BA

Boeing

$354.90

7.71 (2.22%)

, EADSY

Airbus

$0.00

(0.00%)

17:17
06/17/19
06/17
17:17
06/17/19
17:17
Periodicals
Boeing gets zero new plane orders at Paris Air Show so far, CNBC says »

According to CNBC's…

BA

Boeing

$354.90

7.71 (2.22%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

17:17
06/17/19
06/17
17:17
06/17/19
17:17
Syndicate
Breaking Syndicate news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MELR

Melrose Bancorp

$18.40

-0.1 (-0.54%)

17:14
06/17/19
06/17
17:14
06/17/19
17:14
Hot Stocks
Breaking Hot Stocks news story on Melrose Bancorp »

Melrose Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$55.40

0.66 (1.21%)

17:13
06/17/19
06/17
17:13
06/17/19
17:13
Hot Stocks
Cisco awarded maximum $724.1M Defense Information Systems Agency contract »

Cisco has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 16

    Jul

  • 14

    Aug

NI

NiSource

$29.16

0.41 (1.43%)

17:10
06/17/19
06/17
17:10
06/17/19
17:10
Periodicals
NiSource plans sale of unit tied to gas explosions, Bloomberg says »

According to a story from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEO

American Eagle

$17.96

0.38 (2.16%)

17:08
06/17/19
06/17
17:08
06/17/19
17:08
Conference/Events
American Eagle management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

EVOP

EVO Payments

$29.60

-0.03 (-0.10%)

17:07
06/17/19
06/17
17:07
06/17/19
17:07
Hot Stocks
EVO Payments, TouchBistro to partner on payment solutions for Mexico restaurants »

EVO Payments announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDHL

RedHill Biopharma

$7.19

-0.01 (-0.14%)

17:04
06/17/19
06/17
17:04
06/17/19
17:04
Hot Stocks
Ibex Investors reports 5.1% passive stake in RedHill Biopharma »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLD

Steel Dynamics

$26.23

-0.19 (-0.72%)

17:02
06/17/19
06/17
17:02
06/17/19
17:02
Hot Stocks
Breaking Hot Stocks news story on Steel Dynamics »

Steel Dynamics down 2.8%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLD

Steel Dynamics

$26.23

-0.19 (-0.72%)

17:01
06/17/19
06/17
17:01
06/17/19
17:01
Earnings
Steel Dynamics guides Q2 EPS 86c-90c, consensus 99c »

The company says Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$225.00

10.19 (4.74%)

, TWTR

Twitter

$36.40

0.25 (0.69%)

16:56
06/17/19
06/17
16:56
06/17/19
16:56
Hot Stocks
Tesla chief Elon Musk deletesTwitter account »

Over the weekend the…

TSLA

Tesla

$225.00

10.19 (4.74%)

TWTR

Twitter

$36.40

0.25 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

ATO

Atmos Energy

$104.66

-0.34 (-0.32%)

16:54
06/17/19
06/17
16:54
06/17/19
16:54
Conference/Events
Atmos Energy management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TW

Tradeweb Markets

$41.77

0.33 (0.80%)

16:54
06/17/19
06/17
16:54
06/17/19
16:54
Initiation
Tradeweb Markets initiated  »

Tradeweb Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PINS

Pinterest

$27.81

0.41 (1.50%)

16:52
06/17/19
06/17
16:52
06/17/19
16:52
Initiation
Pinterest initiated  »

Wedbush starts Pinterest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

HEXO Corp

$5.50

-0.095 (-1.70%)

, TAP

Molson Coors

$53.66

-0.34 (-0.63%)

16:51
06/17/19
06/17
16:51
06/17/19
16:51
Periodicals
HEXO and Molson plan cannabis-infused drinks by December, Bloomberg says »

HEXO (HEXO) is partnering…

HEXO

HEXO Corp

$5.50

-0.095 (-1.70%)

TAP

Molson Coors

$53.66

-0.34 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 31

    Jul

CWEN

Clearway Energy

$16.31

0.205 (1.27%)

16:49
06/17/19
06/17
16:49
06/17/19
16:49
Hot Stocks
Clearway Energy announces equity commitment in repowering partnership »

Clearway Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNBT

Generex

$0.00

(0.00%)

16:46
06/17/19
06/17
16:46
06/17/19
16:46
Conference/Events
Generex to hold a conference call »

President & CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$287.35

1.97 (0.69%)

16:46
06/17/19
06/17
16:46
06/17/19
16:46
Earnings
Anthem reaffirms FY19 EPS greater than $19.20, consensus $19.30 »

Officers of Anthem will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$18.95

-0.255 (-1.33%)

16:44
06/17/19
06/17
16:44
06/17/19
16:44
Initiation
Rattler Midstream initiated  »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$27.93

-0.1 (-0.36%)

16:42
06/17/19
06/17
16:42
06/17/19
16:42
Upgrade
BMO upgrades Bank of America to Outperform, sees 34% return potential »

BMO Capital analyst James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

FMAO

Farmers & Merchants

$28.45

0.15 (0.53%)

16:37
06/17/19
06/17
16:37
06/17/19
16:37
Hot Stocks
Farmers & Merchants appoints Benet Rupp as CPO »

Farmers & Merchants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.